Nasal allergies and beyond: a clinical review of the pharmacology, efficacy, and safety of mometasone furoate

被引：0

作者：

van Drunen, C

Meltzer, EO

Bachert, C

Bousquet, J

Fokkens, WJ

机构：

[1] Univ Amsterdam, Acad Med Ctr, Dept Otorhinolaryngol, NL-1100 DD Amsterdam, Netherlands

[2] Allergy & Asthma Med Grp & Res Ctr, San Diego, CA USA

[3] Ghent Univ Hosp, ENT Dept, B-9000 Ghent, Belgium

[4] Cent Hosp Univ, Hop Arnaud de Villeneuve, Dept Resp Dis, Montpellier, France

来源：

ALLERGY | 2005年 / 60卷

关键词：

mometasone furoate; allergic rhinitis; nasal allergies; intranasal corticosteroids;

D O I：

暂无

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

Mometasone furoate nasal spray (MFNS; Nasonex(R), Schering-Plough Corporation, Kenilworth, NJ, USA) is an effective and well-tolerated intranasal corticosteroid approved for the prophylactic treatment of seasonal allergic rhinitis, and the treatment of perennial allergic rhinitis. MFNS is a potent molecule with a rapid onset of action and excellent safety and efficacy profiles. Having recently received approval for the treatment of nasal polyposis, data indicate that MFNS may also be effective in rhinosinusitis.

引用

页码：5 / 19

页数：15

共 50 条

[21] The efficacy and safety of mometasone furoate delivered via a dry powder inhaler for the treatment of asthma
Meltzer, Eli O.
Wenzel, Sally
JOURNAL OF ASTHMA, 2006, 43 (10) : 765 - 772
[22] Comparison of the efficacy and safety of mometasone furoate to other inhaled steroids for asthma: a meta-analysis
Yang, Daniel
Wang, Jianmiao
Bunjhoo, Hansvin
Xiong, Weining
Xu, Yongjian
Zhao, Jianping
ASIAN PACIFIC JOURNAL OF ALLERGY AND IMMUNOLOGY, 2013, 31 (01) : 26 - 35
[23] Efficacy, safety, and tolerability of mometasone furoate in adult Japanese patients with mild asthma: open-label clinical trial findings
Tohda, Yuji
Miyamoto, Terumasa
CURRENT MEDICAL RESEARCH AND OPINION, 2010, 26 (01) : 203 - 212
[24] Clinical safety and efficacy of a single-dose gentamicin, posaconazole and mometasone furoate otic suspension for treatment of canine otitis externa
Heuer, Lea
Wilhelm, Cornelia
Roy, Olivier
Loehlein, Wolfgang
Wolf, Oliver
Zschiesche, Eva
VETERINARY RECORD, 2024, 194 (09) : no
[25] CLINICAL EFFICACY OF MOMETASONE FUROATE INHALATION THERAPY IN ADULTS WITH POST-UPPER RESPIRATORY TRACT INFECTION COUGH
Feng, Shanshan
Zhan, Guowen
Jing, Xiaoya
Chen, Yanyan
Yang, Youxiong
Wang, Hongli
FARMACIA, 2016, 64 (05) : 780 - 784
[26] Efficacy of mometasone furoate nasal spray in the treatment of allergic rhinitis. Meta-analysis of randomized, double-blind, placebo-controlled, clinical trials
Penagos, M.
Compalati, E.
Tarantini, F.
Baena-Cagnani, C. E.
Passalacqua, G.
Canonica, G. W.
ALLERGY, 2008, 63 (10) : 1280 - 1291
[27] Clinical study of the effect of mometasone furoate nasal spray treatment on hearing and in secretory otitis media in children
Yu, Xiaoyan
Xu, Lang
Xie, Youqi
Huang, Mengjie
CLINICS, 2025, 80
[28] Efficacy of mometasone furoate nasal spray for nasal symptoms, quality of life, rhinitis-disturbed sleep, and nasal nitric oxide in patients with perennial allergic rhinitis
Yamada, Takechiyo
Yamamoto, Hideyuki
Kubo, Seita
Sakashita, Masafumi
Tokunaga, Takahiro
Susuki, Dai
Narita, Norihiko
Ogi, Kazuhiro
Kanno, Masafumi
Yamashita, Shinji
Terasawa, Yuko
Kayano, Yuichiro
Masada, Mikio
Fujieda, Shigeharu
ALLERGY AND ASTHMA PROCEEDINGS, 2012, 33 (02) : E9 - E16
[29] A phase 3 study evaluating the safety and efficacy of a pediatric dose of mometasone furoate with and without formoterol for persistent asthma
Weinstein, Cindy L. J.
Gates, Davis
Zhang, Xiaoli
Varnell, Tracey
Mok, Wilson
Vermeulen, Jan H.
Amar, Niran J.
Jain, Neal
PEDIATRIC PULMONOLOGY, 2020, 55 (04) : 882 - 889
[30] Efficacy and safety of fluticasone furoate nasal spray in Chinese adult and adolescent subjects with intermittent or persistent allergic rhinitis
Han, Demin
Liu, Shixi
Zhang, Yuan
Wang, Jiadong
Wang, Dehui
Kong, Weijia
Wang, Shenqing
Cheng, Lei
Zhang, Luo
ALLERGY AND ASTHMA PROCEEDINGS, 2011, 32 (06) : 472 - 481

← 1 2 3 4 5 →